138 related articles for article (PubMed ID: 10509383)
21. FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex.
Xia W; Ostaszewski BL; Kimberly WT; Rahmati T; Moore CL; Wolfe MS; Selkoe DJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):673-81. PubMed ID: 11114265
[TBL] [Abstract][Full Text] [Related]
22. Human wild presenilin-1 mimics the effect of the mutant presenilin-1 on the processing of Alzheimer's amyloid precursor protein in PC12D cells.
Kametani F; Tanaka K; Usami M; Maruyama K; Mori H
J Neurol Sci; 2001 Jul; 188(1-2):27-31. PubMed ID: 11489281
[TBL] [Abstract][Full Text] [Related]
23. Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation.
Pigino G; Pelsman A; Mori H; Busciglio J
J Neurosci; 2001 Feb; 21(3):834-42. PubMed ID: 11157069
[TBL] [Abstract][Full Text] [Related]
24. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein.
Citron M; Eckman CB; Diehl TS; Corcoran C; Ostaszewski BL; Xia W; Levesque G; St George Hyslop P; Younkin SG; Selkoe DJ
Neurobiol Dis; 1998 Aug; 5(2):107-16. PubMed ID: 9746908
[TBL] [Abstract][Full Text] [Related]
25. Alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease.
Ancolio K; Marambaud P; Dauch P; Checler F
J Neurochem; 1997 Dec; 69(6):2494-9. PubMed ID: 9375682
[TBL] [Abstract][Full Text] [Related]
26. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.
Walker ES; Martinez M; Brunkan AL; Goate A
J Neurochem; 2005 Jan; 92(2):294-301. PubMed ID: 15663477
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes.
Leissring MA; Paul BA; Parker I; Cotman CW; LaFerla FM
J Neurochem; 1999 Mar; 72(3):1061-8. PubMed ID: 10037477
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis.
Tanii H; Ankarcrona M; Flood F; Nilsberth C; Mehta ND; Perez-Tur J; Winblad B; Benedikz E; Cowburn RF
Neuroscience; 2000; 95(2):593-601. PubMed ID: 10658639
[TBL] [Abstract][Full Text] [Related]
29. Effects of human presenilin 1 isoforms on proliferation and survival of rat pheochromocytoma cell line PC12.
Bobrysheva IV; Grigorenko AP; Novosadova EV; Kal'ina NR; Arsenyeva EL; Grivennikov IA; Tarantul VZ; Rogaev EI
Biochemistry (Mosc); 2003 Jun; 68(6):611-7. PubMed ID: 12943504
[TBL] [Abstract][Full Text] [Related]
30. Implications of presenilin 1 mutations in Alzheimer's disease.
Komano H; Sudoh S; Kawamura Y; Wang R; Yanagisawa K
Mech Ageing Dev; 1999 Mar; 107(3):281-98. PubMed ID: 10360683
[TBL] [Abstract][Full Text] [Related]
31. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
[TBL] [Abstract][Full Text] [Related]
32. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response.
Katayama T; Imaizumi K; Sato N; Miyoshi K; Kudo T; Hitomi J; Morihara T; Yoneda T; Gomi F; Mori Y; Nakano Y; Takeda J; Tsuda T; Itoyama Y; Murayama O; Takashima A; St George-Hyslop P; Takeda M; Tohyama M
Nat Cell Biol; 1999 Dec; 1(8):479-85. PubMed ID: 10587643
[TBL] [Abstract][Full Text] [Related]
33. Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest.
Janicki SM; Stabler SM; Monteiro MJ
Neurobiol Aging; 2000; 21(6):829-36. PubMed ID: 11124426
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of neurite outgrowth by familial Alzheimer's disease-linked presenilin-1 mutations.
Dowjat WK; Wisniewski T; Efthimiopoulos S; Wisniewski HM
Neurosci Lett; 1999 May; 267(2):141-4. PubMed ID: 10400232
[TBL] [Abstract][Full Text] [Related]
35. Dual roles of proteasome in the metabolism of presenilin 1.
Honda T; Yasutake K; Nihonmatsu N; Mercken M; Takahashi H; Murayama O; Murayama M; Sato K; Omori A; Tsubuki S; Saido TC; Takashima A
J Neurochem; 1999 Jan; 72(1):255-61. PubMed ID: 9886077
[TBL] [Abstract][Full Text] [Related]
36. Alternative splicing in the N-terminus of Alzheimer's presenilin 1.
Scheper W; Zwart R; Baas F
Neurogenetics; 2004 Dec; 5(4):223-7. PubMed ID: 15480879
[TBL] [Abstract][Full Text] [Related]
37. Presenilin 1 mutations linked to familial Alzheimer's disease increase the intracellular levels of amyloid beta-protein 1-42 and its N-terminally truncated variant(s) which are generated at distinct sites.
Sudoh S; Kawamura Y; Sato S; Wang R; Saido TC; Oyama F; Sakaki Y; Komano H; Yanagisawa K
J Neurochem; 1998 Oct; 71(4):1535-43. PubMed ID: 9751187
[TBL] [Abstract][Full Text] [Related]
38. [Biochemistry of presenilin 1].
Takashima A
Rinsho Shinkeigaku; 1997 Dec; 37(12):1097-8. PubMed ID: 9652956
[TBL] [Abstract][Full Text] [Related]
39. Presenilin 1 mutations in Polish families with early-onset Alzheimer's disease.
Kowalska A; Pruchnik-Wolińska D; Florczak J; Szczech J; Kozubski W; Rossa G; Wender M
Folia Neuropathol; 2004; 42(1):9-14. PubMed ID: 15119739
[TBL] [Abstract][Full Text] [Related]
40. Effects of RNAi-mediated silencing of PEN-2, APH-1a, and nicastrin on wild-type vs FAD mutant forms of presenilin 1.
Xie Z; Romano DM; Tanzi RE
J Mol Neurosci; 2005; 25(1):67-77. PubMed ID: 15781968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
